Best PT-141 Providers in 2026 — Ranked & Reviewed
PT-141 (bremelanotide) is prescribed for low sexual desire and works through the central melanocortin pathway rather than blood flow, which is what distinguishes it from the ED medications it often sits alongside. It requires a prescription. Every provider below prescribes it through a licensed clinician and is scored on the same dimensions as the rest of our catalog.
29 providers compared
New to PT-141? Read our full PT-141 guide — evidence, dosing, safety and side effects.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
29 pt-141 providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
a low all-in starter price on compounded GLP-1s, with every dose price published up front
From /moCheck pricingCoverage50 statesMedicationsBPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141SermorelinTB-500Tesamorelin - Nationwide Coverage
Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
From /moCheck pricingCoverage50 statesMedicationsGHK-CuGlutathioneNAD+PT-141Sermorelin - Transparent Pricing
flat-price compounded GLP-1 with named pharmacies and no membership fee
From /moCheck pricingCoverage46 statesMedicationsNAD+PT-141Sermorelin Bryan Johnson's longevity brand: compounded microdose GLP-1 from $167/mo
From /moCheck pricingCoverageCheck intakeMedicationsGlutathioneNAD+PT-141Sermorelincompounded GLP-1 with no auto-subscribe, plus brand-name options and a wellness menu on one account
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+PT-141SermorelinNeedle-free, microdosed compounded GLP-1 with lab-monitored care
From /moCheck pricingCoverageCheck intakeMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuIpamorelinNAD+PT-141SermorelinTB-500Californians and Arizonans who want compounded GLP-1 inside a lab-driven clinic
From /moCheck pricingCoverage2 statesMedicationsGHK-CuGlutathioneNAD+PT-141Sermorelinpremixed, ready-to-inject compounded GLP-1 plus brand Wegovy and Zepbound options
From /moCheck pricingCoverage48 statesMedicationsGlutathioneNAD+PT-141Sermorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick a low all-in starter price on compounded GLP-1s, with every dose price published up front | Check pricing | BPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141SermorelinTB-500Tesamorelin | 50 states | Visit → | |
Nationwide Coverage Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up | Check pricing | GHK-CuGlutathioneNAD+PT-141Sermorelin | 50 states | Visit → | |
Transparent Pricing flat-price compounded GLP-1 with named pharmacies and no membership fee | Check pricing | NAD+PT-141Sermorelin | 46 states | Visit → | |
 Bryan Johnson's longevity brand: compounded microdose GLP-1 from $167/mo | Check pricing | GlutathioneNAD+PT-141Sermorelin | Check intake | Visit → | |
 compounded GLP-1 with no auto-subscribe, plus brand-name options and a wellness menu on one account | Check pricing | GHK-CuGlutathioneNAD+PT-141Sermorelin | Check intake | Visit → | |
 Needle-free, microdosed compounded GLP-1 with lab-monitored care | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuIpamorelinNAD+PT-141SermorelinTB-500 | Check intake | Visit → | |
 Californians and Arizonans who want compounded GLP-1 inside a lab-driven clinic | Check pricing | GHK-CuGlutathioneNAD+PT-141Sermorelin | 2 states | Visit → | |
 premixed, ready-to-inject compounded GLP-1 plus brand Wegovy and Zepbound options | Check pricing | GlutathioneNAD+PT-141Sermorelin | 48 states | Visit → |
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
A note on prices below: any dollar figure in these provider summaries refers to that clinic’s GLP‑1 weight-loss program, not to PT-141. The PT-141 price is the one beside each clinic in the comparison table above, read from that clinic’s own product page. Where it reads “Check pricing”, the clinic prescribes PT-141 but publishes no price for it — you are quoted after the consultation.
Pepti
Best for: a low all-in starter price on compounded GLP-1s, with every dose price published up front
Pepti is a Delaware-registered telehealth platform selling doctor-prescribed compounded peptides and GLP-1s, with a published shipping list of 49 states plus DC. Injectable semaglutide starts at $99 and tirzepatide at $159 per 28-day supply, rising with dose to $199 and $319. Each price covers medication, physician review, labs, refill management and shipping, with no membership fee. Pepti is a platform, not a prescriber, and does not bill insurance.
Score Breakdown
Pros
- ✓Injectable semaglutide starts at $99 and tirzepatide at $159 all-in, with no membership fee on top.
- ✓Publishes the exact price for every dose of both drugs, so you can see what titrating up will cost before you start.
- ✓Publishes a shipping list of 49 states plus DC, and a provider denial means a full refund.
- ✓Names the reviewing physician, Dr. Gene Lee MD, and posts third-party sterility and potency results by lot.
Cons
- ✗Billed every 28 days rather than monthly, so you pay 13 times a year, not 12.
- ✗Price rises with dose: semaglutide tops out at $199 and tirzepatide at $319 per supply.
- ✗The site says it serves 50 states, but its own list leaves out Oklahoma and counts DC instead.
- ✗No compounding pharmacy is named in advance; you only learn it from your medication label.
- ✗The listed address, a Newark Delaware suite, is a shared registered-agent address rather than a clinical office.
- ✗Cash-pay only with no insurance billing, and medication can't be refunded once it ships.
YourHealthRx
Best for: Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform that connects patients with independent clinicians and 503A compounding pharmacies in all 50 states (not DC). Compounded semaglutide is $170/month and tirzepatide $210/month month-to-month, with lower 3- and 6-month upfront plans and the same price at every dose. Oral tablets are also offered. Compounded meds aren't FDA-approved, the pharmacy isn't named, and refunds are rarely available once intake starts.
Score Breakdown
Pros
- ✓Available in all 50 states through a multi-state licensed clinician network
- ✓Compounded semaglutide and tirzepatide in two formats: weekly injectable or daily oral dissolving tablet
- ✓Flat price that doesn't change as your dose increases
- ✓Prices shown upfront, and the monthly price includes prescription, medication, and delivery
- ✓Lower rates on 3- and 6-month plans, plus a broad peptide catalog and lab testing
Cons
- ✗YourHealthRx is a platform, not the prescriber or pharmacy; prescribing runs through partner clinicians
- ✗Compounded medications are not FDA-approved, and are not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗The compounding pharmacy partner is not named
- ✗Refunds are generally not available once intake or clinician review has started
- ✗The lowest advertised rates need a 6-month upfront payment or a promo code; month-to-month is $170 (semaglutide) or $210 (tirzepatide)
- ✗Not available in DC, some injectables can't ship to California, and some states require a video visit
- ✗No LegitScript certification displayed
KIN Health
Best for: flat-price compounded GLP-1 with named pharmacies and no membership fee
KIN Health prescribes compounded semaglutide at $169/mo and compounded tirzepatide at $199/mo, one price at every dose, with the provider review, messaging and shipping included and no membership fee. Prescribers are contracted through MD Integrations, and the dispensing pharmacies are named: Strive, Boothwyn and Drug Crafters. Each month is paid for separately, with no long plan to sign. Sermorelin, NAD+ and PT-141 are sold on the same account.
Score Breakdown
Pros
- ✓One flat price at every dose: $169/mo semaglutide and $199/mo tirzepatide, shown on the product page before any quiz
- ✓Provider review, ongoing messaging and shipping are included, with no membership fee and no separate consultation charge
- ✓Names who does the work: prescribers through MD Integrations and three pharmacies, Strive, Boothwyn and Drug Crafters
- ✓Publishes a provider directory with license numbers for the states that require it
- ✓Month-to-month: each refill needs your approval, and you are refunded in full if a provider does not approve treatment
- ✓The company behind it is named: KIN Medical, Inc., a Delaware corporation
- ✓Sermorelin, NAD+ and PT-141 on the same account, each in injection, nasal spray or dissolvable tablet form
Cons
- ✗The terms say tirzepatide's monthly cost may change as your dose rises, which cuts against the flat-price promise on the product page
- ✗Product pages say no subscriptions and no auto-renew, while the terms describe a GLP-1 subscription billed each refill cycle
- ✗No refunds once medication ships, and a refill already sent to the pharmacy cannot be canceled
- ✗GLP-1 care is not offered in California, Louisiana, Minnesota or Mississippi
- ✗Support is by email only, with replies promised within one business day; no phone number is published
- ✗Claims LegitScript certification, but no record could be confirmed in LegitScript's public directory
- ✗Compounded semaglutide and tirzepatide are not FDA-approved, and the formula may include glycine or B12 depending on the pharmacy
- ✗A young brand: its terms took effect in April 2026, so there is little track record to judge
Immortals
Best for: Bryan Johnson's longevity brand: compounded microdose GLP-1 from $167/mo
Immortals is a LegitScript-certified longevity telehealth platform founded by Bryan Johnson, offering compounded semaglutide (Semaglutide/Glycine/B12) and tirzepatide (Tirzepatide/Glycine/B12) as microdose weekly injections. Every subscription includes physician review within 72 hours, prescription fulfillment from licensed U.S. pharmacies, discreet shipping, and unlimited provider messaging for 12 months. Semaglutide starts at $167/month and tirzepatide at $180/month (promotional, billed quarterly). HSA/FSA reimbursable; no insurance required.
Score Breakdown
Pros
- ✓LegitScript certified (ID 50458743) with board-certified U.S. physician review within 72 hours
- ✓Physician consult + prescription bundled in price — "You pay for treatment. That's it" with no added fees
- ✓Competitive pricing: semaglutide microdose from $167/month, tirzepatide from $180/month (promotional)
- ✓Unlimited provider messaging for 12 months included; video consults available
- ✓Founded by Bryan Johnson and Kate Tolo; clinical lead Dr. Carl Seger, M.D. (preventive/longevity medicine)
Cons
- ✗Microdose framing uses sub-clinical doses — lower weight-loss efficacy than standard GLP-1 protocols
- ✗Quarterly commitment only — 3-month minimum, paid upfront ($501–$540/quarter); no monthly flexibility
- ✗State availability not publicly listed; 'eligible U.S. states' with no specific state list
- ✗Labs not included; baseline bloodwork protocol not disclosed on any public page
- ✗Compounding pharmacy not named; no 503A/503B accreditation details disclosed
Kin Meds
Best for: compounded GLP-1 with no auto-subscribe, plus brand-name options and a wellness menu on one account
Kin Meds is a LegitScript-certified telehealth platform offering compounded semaglutide (from $199) and compounded tirzepatide with B12 (from $249), with shipping, supplies and the provider visit included and no auto-subscribe. It also prescribes brand-name Wegovy (injection and pill), Zepbound and Foundayo for a $149/mo consult fee, with the medication filled and billed separately by NovoCare Pharmacy or LillyDirect. A wide wellness menu (NAD+, sermorelin, TRT, hormones, labs) runs on the same account.
Score Breakdown
Pros
- ✓Compounded semaglutide from $199 and tirzepatide from $249, with shipping, supplies and the provider visit included
- ✓No auto-subscribe: choose a 30- or 90-day supply and skip a month when you need to
- ✓Brand-name Wegovy (injection and pill), Zepbound and Foundayo available through the manufacturers' own pharmacies
- ✓LegitScript certified
- ✓Names its partner pharmacies (Rush Pharmacy and Strive Pharmacy)
- ✓Provider review in 24 hours or less, and you are not charged for treatment if it isn't appropriate
- ✓Wide wellness menu (NAD+, sermorelin, TRT, hormones, labs) on one account
Cons
- ✗Brand-name care costs a $149/mo consult fee on top of the medication, which you buy separately from NovoCare or LillyDirect
- ✗Compounded prices are 'starting at' figures; the price at higher doses isn't shown before you sign up
- ✗Orders can't be changed or canceled once processing starts, and all medication sales are final
- ✗Asks for your email before any health questions, and the intake requires a photo ID and selfie
- ✗Legal entity name isn't clearly disclosed on the site
- ✗Does not accept insurance
- ✗Breadth across 8+ care areas makes it a general wellness platform, not a GLP-1 specialist
How to choose a PT-141 provider
PT-141 (bremelanotide) is the one molecule in this category with a real FDA approval — as Vyleesi, for hypoactive sexual desire disorder in premenopausal women. Most telehealth clinics sell a compounded version, often to men, which is off-label use of an approved molecule.
What to look for
- Know whether you are getting Vyleesi or a compound. The approved autoinjector and a compounded vial are not the same product, are not priced the same, and do not carry the same labeling. A clinic should say plainly which one it dispenses.
- On-demand dosing, not daily. PT-141 is taken before anticipated activity, not on a daily schedule. A clinic selling it as a daily regimen has the dosing model wrong.
- Blood-pressure screening. Bremelanotide transiently raises blood pressure and lowers heart rate, and is contraindicated in uncontrolled hypertension or known cardiovascular disease. A clinic that never asks is skipping the main safety check.
Red flags to avoid
- “Research peptides” sold without a prescriber. Vials labeled “for research use only — not for human consumption” are sold outside the drug-approval system entirely, with no verified identity, purity, or sterility. Every peptide in this category is prescription-only in the US; if no licensed clinician is writing a prescription, you are not buying the same product.
- No named 503A or 503B compounding pharmacy. There is no FDA-approved finished product for these peptides, so every legitimate dose comes from a compounding pharmacy. A clinic that will not name the pharmacy it dispenses through is asking you to trust an unverifiable supply chain.
- “FDA-approved” claimed for a compounded peptide. Compounded drugs are not FDA-approved, and saying otherwise is a marketing violation, not a technicality. Some peptides once held an approval for a different indication in a discontinued brand — that is not the same as the compounded product being approved.
- Outcome claims with no trial behind them. Most peptides in this category have mechanistic or early-phase evidence, not randomized outcome trials. A clinic promising a specific fat-loss, muscle, or anti-aging result is selling ahead of the evidence — check our evidence review for the molecule before you commit.
- No baseline labs or follow-up for hormone-axis peptides. Growth-hormone secretagogues raise IGF-1, which is the point and also the thing to monitor. A clinic that never measures it cannot tell whether you are responding or over-dosed.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- 503A pharmacy · Pharmacy and drug forms
- 503A vs 503B (pharmacy compounding) · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.